Novai Company
Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.
Total Funding:
5328528
Headquarters:
Reading, Reading, United Kingdom
Funding Status:
Seed
Employee Number:
11-50
Last Funding Type:
Seed
Last Funding Date:
2023-01-24
Investors Number:
2
Founded Date:
2020-02-12
Industry:
Aging Biomarkers